Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001193125-25-180317·BALYASNY ASSET MANAGEMENT L.P.
Schedule 13G ownership disclosure
Lexeo Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 52886X107
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Balyasny Asset Management L.P.
Shares: 8,345,651 · Class: 9.99%
- BAM GP LLC
Shares: 8,345,651 · Class: 9.99%
- Balyasny Asset Management Holdings LP
Shares: 8,345,651 · Class: 9.99%
- Dames GP LLC
Shares: 8,345,651 · Class: 9.99%
- Dmitry Balyasny
Shares: 8,345,651 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-180317
- Form type
- SCHEDULE 13G
- Filer
- BALYASNY ASSET MANAGEMENT L.P.
- CIK
- CIK 1218710
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership